Alan M. Garber

Alan M. Garber, MD, PhD

Provost, Harvard University; Mallinckrodt Professor of Health Care Policy, Professor of Economics, Harvard Kennedy School and the Faculty of Arts and Sciences
Harvard Medical SchoolDepartment of Health Care Policy180 Longwood AvenueBoston, MA 02115-5899
Predicting high-risk cholesterol levels
Authors: Garber AM, Olshen RA, Zhang H, et al.
International Statistical Review
View full abstract on Pubmed
Triglyceride concentration and coronary heart disease (editorial)
Authors: Garber AM and Avins AL
British Medical Journal
View full abstract on Pubmed
Can technology assessment control health spending?

Health Affairs
View full abstract on Pubmed
Alglucerase for Gaucher's Disease: dose, costs, and benefits
Authors: Beutler E and Garber AM
PharmacoEconomics
View full abstract on Pubmed
Benefits vs. profits: has the Orphan Drug Act gone too far?

Pharmacoeconomics
View full abstract on Pubmed
Nursing home discharges and exhaustion of Medicare benefits
Authors: Garber AM and MaCurdy T
Journal of the American Statistical Association
View full abstract on Pubmed
Should we be measuring blood cholesterol levels in young adults?
Authors: Hulley SB, Newman TB, Grady D, et al.
Journal of the American Medical Association
View full abstract on Pubmed
Is high flux dialysis cost effective?
Authors: Hornberger J, Garber AM and Chernew ME
International Journal of Technology Assessment in Health Care
View full abstract on Pubmed
A multivariate analysis of mortality and hospital admissions with high flux dialysis
Authors: Hornberger J, Chernew ME, Petersen J, et al.
Journal of the American Society of Nephrology
View full abstract on Pubmed
Creating the costliest orphan: the Orphan Drug Act in the development of Ceredase
Authors: Goldman DP, Clarke AE and Garber AM
International Journal of Technology Assessment in Health Care
View full abstract on Pubmed